Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elekta Board/Management Information 2021

Feb 25, 2021

2906_rns_2021-02-25_840192f9-0afa-421c-a7c5-e2627c95dc96.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Elekta

Press release: February 25, 2021

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM – Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO since June 2, 2020.

Prior to the Acting CFO position, Johan Adebäck had been Group Treasurer at Elekta since 2004, responsible for Treasury, Taxes, Customer Financing, Operational accounting and Customer Credit Risk. He has held senior positions within finance at Pharmacia and Esselte.

"I have worked closely with Johan since I began at Elekta almost 12 years ago and have always been impressed by his integrity, diligence and proficiency," said Elekta's President and CEO, Gustaf Salford. "Working side-by-side with him over the past nine months has confirmed that he also has the spirit and competence to succeed in this role."

Johan Adebäck holds a Bachelor's degree in Business Administration and Economics from Stockholm University.

For further information, please contact:

Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail: [email protected]
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: [email protected]
Time zone: CET: Central European Time

This is information that Elekta AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 07:29 CET on February 25, 2021. (REGMAR)

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.